Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech Advisory Board Member Presented at CannMed 2017 Personalized Cannabinoid Medicine Conference at Harvard
13. April 2017 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, April 13, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that Dr. Ilya Reznik, a...
Dr. Ilya Reznik
AXIM® Biotech Expands Advisory Board With Psychiatry Specialist – Dr. Ilya Reznik
13. Dezember 2016 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, Dec. 13, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, announces the addition to its advisory...